Intracranial aneurysms (IAs), as a common cerebrovascular disease, claims a worldwide
morbidity rate of 3.2%. Inflammation, pivotal in the pathogenesis of IAs, influences their …

Background: Inflammation is a key element behind the pathophysiology of cerebral
aneurysm formation and rupture. Aspirin is a potent inhibitor of cyclooxygenase-2 (COX) …

Objectives Aspirin has been suggested as a potential therapeutic strategy to prevent the
growth and rupture of unruptured intracranial aneurysms (UIAs), but there is still controversy …

OBJECTIVE Aspirin has emerged as a potential agent in the prevention of rupture of
intracranial aneurysms (IAs). In this study, the authors' goal was to test if aspirin is protective …

The biology of intracranial aneurysms (IA) has been under intense investigation over the
past two decades. 1-7 Despite recent advances in neurosurgery, morbidity and mortality …

Approximately 2% of the general population harbor saccular intracranial aneurysms (IAs),
lesions that are largely asymptomatic unless they rupture and produce a subarachnoid …

Objective: To evaluate the association between aspirin use and the risks of unruptured
intracranial aneurysm (UIA) growth and aneurysmal subarachnoid hemorrhage (aSAH) …

Background and Purpose—Chronic inflammation is postulated as an important
phenomenon in intracranial aneurysm wall pathophysiology. This study was conducted to …

Subarachnoid hemorrhage (SAH) usually occurs with a thunderclap headache or the worst
headache of a patient's life, leading to a neurologic emergency. Among cases of …

Objective Recent evidence has suggested a potential beneficial effect of aspirin on the risk
of aneurysm rupture. This benefit must be weighed against its potential adverse effects as an …